Prevalence of Obesity in Patients with Dysphonia

Haddad, Ghassan; Hage, Aya El; Yammine, Yara; Hamdan, Abdul‐Latif

doi:10.1016/j.jvoice.2021.12.001

Cited by 1 publication

(2 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, we showed that the bias resulting from this discrepancy was very limited, and we were able to estimate an adjusted relative risk that was significantly greater than 1. Asthmatic population exhibited higher BMI than control and dysphonia has been described more prevalent in obese population 43 . Although, in our study, we did not observed a significantly higher rate of patients with a BMI >30.…”

Section: Discussioncontrasting

confidence: 75%

See 1 more Smart Citation

Laryngeal dysfunction is prominent in asthmatic women treated by inhaled corticosteroids

Migueres

Delmas²,

Thomas

et al. 2022

Clinical & Translational All

View full text Add to dashboard Cite

Background Dysphonia is a frequent comorbidity of asthma and has been suggested to be a local side effect of inhaled corticosteroids due to laryngeal candidiasis. We hypothesized that dysphonia in asthmatics was not due to laryngeal organic lesions but to laryngeal dysfunction during phonation (LDP). Objective We compared the frequency of LDP in female asthmatic patients treated with inhaled corticosteroids to female controls. Methods We compared 68 asthmatic female patients to 53 female control subjects. Pulmonary function tests were performed and the asthmatic patients classified according to the level of inhaled corticosteroids. Dysphonia was defined as a Vocal Handicap Index ≥18 or GRBAS score ≥2. All patients underwent video laryngo‐strobe examination, analyzed blindly and separately by two otolaryngologists, describing mucosal changes, LDP, or Organic lesions linked to Laryngeal Dysfunction during Phonation (OLDP). Results 66.2% of the asthmatic patients exhibited dysphonia and 11.3% of controls ( p < 0.001). No laryngeal candidiasis was found, only 3 patients presented laryngeal mucosa inflammation. LDP was observed in 60.3% of asthmatic patients and 18.9% of controls ( p < 0.001), and no difference was found for OLDP (11.8% vs. 13.2%). No association was made between LDP, the dosage of inhaled corticosteroid, and bronchial obstruction. Conclusions Asthmatic patients were more dysphonic than control subjects. This phenomenon was not explained by mucosal inflammation, laryngeal candidiasis or OLDP. Asthmatic patients had more LDP than controls. There was no relation between LDP, inhaled corticosteroids dosage or bronchial obstruction. These results change our view of inhaled corticosteroid side effects in female asthmatic patients.

show abstract

Section: Discussioncontrasting

confidence: 75%

“…Asthmatic population exhibited higher BMI than control and dysphonia has been described more prevalent in obese population. 43 Although, in our study, we did not observed a significantly higher rate of patients with a BMI >30. The video‐laryngo‐stroboscopic exam was realized during phonatory tasks and not connected speech.…”

Section: Discussioncontrasting

confidence: 72%